Characteristics and Vaccine Booster Effectiveness in Covid-19 Infections Using 15 Days Post-Booster Period as Baseline during the Omicron Wave in A General Medicine office in Toledo (Spain)

作者
José Luis Turabián
出处
期刊:General medicine and clinical practice [Auctores Publishing LLC]
卷期号:5 (2): 01-09 被引量:1
标识
DOI:10.31579/2639-4162/050
摘要

Background: Vaccine covid-19 booster effectiveness (VBE) timing is not clearly known Objective: To compare the cases of covid-19 in vaccinated booster people with a time of <15 days vs. >= 15 days from booster to infection diagnosis and assess their relative VBE. Methodology: An observational, longitudinal and prospective study of adult patients with covid-19 breakthrough infections in booster vaccinated people, in general medicine and for the period December 2021 to February 2022, during the omicron variant contagion wave. Results: Forty-six cases were included, 15 cases of Covid-19 breakthrough infections with booster shot <15 days (33%) with a mean time in days from booster to diagnostic covid-19 of 6 days, and 31 cases with booster > = 15 days (67%) with a time in days from booster to covid-19 diagnostic of 37 days of mean. Relative VBE <15 days (cases where it can be considered that the booster is not yet effective) vs. > = 15 days (cases where it can be considered that the booster is already effective) [1 - (Cases with vaccine Booster shot < 15 days) / (Cases with vaccine Booster shot > = 15 days) x 100] was 60%. Covid-19 cases with booster shot <15 days had been more vaccinated with 2 doses of ChAdOx1 nCoV-19 vaccine (Vaxzevria, Oxford / AstraZeneca) plus booster of mRNA-1273 vaccine (Spikevax, formerly covid-19 Vaccine Moderna). Conclusion: In the general practice setting in Toledo, Spain, from December 1, 2021 to February 28, 2022, at the peak of omicron infections, booster after a period of <15 days provided 60% relative protection against symptomatic disease vs. > = 15 days. The results suggest that booster received <15 days provided early protection against SARS-CoV-2 infection of symptomatic Covid-19 of 60%. However, this result does not seem logical: this lower early risk may be transient and due to “vaccinated bias.”

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
Connor发布了新的文献求助10
刚刚
乔晶完成签到,获得积分10
1秒前
1秒前
科研通AI6.4的应助被HYT采纳,获得10
2秒前
2秒前
4秒前
一个巨型懒懒完成签到,获得积分10
5秒前
auc完成签到,获得积分10
5秒前
NexusExplorer的应助被王明初采纳,获得10
5秒前
烟花的应助被Lwb采纳,获得10
6秒前
华仔的应助被科研通管家采纳,获得10
6秒前
Jasper的应助被科研通管家采纳,获得10
6秒前
tiptip的应助被科研通管家采纳,获得30
6秒前
今后的应助被科研通管家采纳,获得10
6秒前
酷波er的应助被科研通管家采纳,获得10
7秒前
Jasper的应助被科研通管家采纳,获得10
7秒前
12345678发布了新的文献求助10
7秒前
情怀的应助被科研通管家采纳,获得10
7秒前
Owen的应助被科研通管家采纳,获得10
7秒前
赘婿的应助被科研通管家采纳,获得10
7秒前
深情安青的应助被科研通管家采纳,获得10
7秒前
7秒前
深情安青的应助被科研通管家采纳,获得10
7秒前
打打的应助被科研通管家采纳,获得10
8秒前
丘比特的应助被YYY采纳,获得10
8秒前
打打的应助被科研通管家采纳,获得10
8秒前
Akim的应助被科研通管家采纳,获得10
8秒前
8秒前
大模型的应助被科研通管家采纳,获得10
8秒前
小蘑菇的应助被科研通管家采纳,获得10
8秒前
8秒前
9秒前
DDD发布了新的文献求助10
9秒前
9秒前
傲娇的冷之完成签到,获得积分10
9秒前
aaaa的应助被李子阳采纳,获得60
9秒前
野葱完成签到,获得积分10
11秒前
诗酒趁年华完成签到,获得积分10
11秒前
思谷完成签到,获得积分10
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Aspects of Post-SPE Phonology 2000
CODESSA 2000
Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals 888
Rosenblum, Global Change Biology 800
Berberine regulates the TLR4 signaling pathway to suppress hypoxia-induced proliferation and migration of pulmonary arterial smooth muscle cells 530
Organizational Behavior 510
热门求助领域 (近24小时)
化学 材料科学 医学 生物 计算机科学 工程类 纳米技术 有机化学 化学工程 内科学 物理 生物化学 复合材料 催化作用 细胞生物学 人工智能 心理学 无机化学 基因 遗传学
热门帖子
关注 科研通微信公众号,转发送积分 7855110
求助须知:如何正确求助?哪些是违规求助? 9373834
关于积分的说明 20690011
捐赠科研通 7453273
什么是DOI,文献DOI怎么找? 3345222
关于科研通互助平台的介绍 2487895
邀请新用户注册赠送积分活动 2368856